Navigation Links
Cytos Biotechnology Ltd Reports Third Quarter 2013 Financial Results and Recent Developments
Date:10/30/2013

>About CytosBiotechnology Ltd

Cytos is a public biopharmaceutical company focused on the development of targeted immuno-therapies. The Company's lead product candidate CYT003 is a novel, first-in-class, immune modulator in Phase 2 clinical development as a potential new treatment for asthma. CYT003 has a novel mechanism of action that inhibits the immune response that causes asthma, and may therefore be beneficial for the control of asthma. In a successfully completed Phase 2a study, CYT003 was shown to maintain asthma control and lung function in patients with persistent allergic asthma, despite withdrawal of standard therapy with inhaled corticosteroids. CYT003 has been shown to have a good safety and tolerability profile in more than 450 individuals receiving the active agent so far. Cytos was founded in 1995 as a spinoff from the Swiss Federal Institute of Technology (ETH) in Zurich. It is located in Schlieren (Zurich), Switzerland. The Company is listed according to the Main Standard on the SIX Swiss Exchange Ltd under the symbol CYTN.

www.cytos.com

Forward Looking Statements

This media release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. You are urged to consider statements that include the words "will" or "expect" or the negative of those words or other similar words to be uncertain and forward-looking. Factors that may cause actual r
'/>"/>

SOURCE Cytos Biotechnology Ltd
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Cytos Biotechnology Strengthens Management Team
2. The Journal of Allergy and Clinical Immunology Publishes Phase 2a Study Results With Cytos Biotechnologys CYT003 for the Treatment of Allergic Asthma
3. Cytos Biotechnology Ltd Reports First Quarter 2013 Financial Results and Recent Development
4. Puma Biotechnology Announces Completion of Private Placement
5. Animal Biotechnology - Technologies, Markets and Companies
6. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
7. Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium
8. JumpStart Invests $250,000 in Milo Biotechnology
9. Global Biotechnology Industry
10. Apexigen and Shanghai Duyiwei Biotechnology Co. Ltd Sign a License and Collaboration Agreement to Develop and Commercialize APX004
11. Lixte Biotechnology Receives US Patent for Its Proprietary Histone Deacetylase Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 10, 2014 OMICS Group’s 5th International ... 18-20 August, 2014 at Double Tree by Hilton Beijing, ... developments in Analytical & Bioanalytical research methods only to ... on this occasion, Dr. Srinubabu Gedela, MD of OMICS ... is a remarkable one in bringing a unique and ...
(Date:7/10/2014)... 10, 2014  Franciscan St. Anthony Health-Crown ... for respiratory monitoring outside the operating room, ... in embracing state-of-the-art patient safety technology. ... breathing and can alert medical caregivers when ... amount of carbon dioxide the patient is ...
(Date:7/10/2014)... 10, 2014 /PRNewswire-iReach/ -- Tute Genomics, the ... announced an agreement with Lineagen, Inc., to ... NextStep Dx PLUS.  Lineagen, focused on ... disorders, currently offers FirstStep Dx PLUS, ... used by healthcare providers as a first-line ...
(Date:7/10/2014)... -- According to the International Atomic Energy Agency ... from terrorists acquiring sufficient quantities of plutonium or ... nuclear explosive device. The IAEA also notes that ... gram-level quantities, which can be challenging to detect ... new study appearing this week in the ...
Breaking Biology Technology:A Critical Review of Analytical Techniques for Improved Living Standards 2A Critical Review of Analytical Techniques for Improved Living Standards 3A Critical Review of Analytical Techniques for Improved Living Standards 4Franciscan St. Anthony Health-Crown Point Underscores Patient Safety Commitment Through Expanded Use of Capnography 2Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 2Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 3Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 4Sensitive detection method may help impede illicit nuclear trafficking 2
... ROCKVILLE, Md., March 9, 2012 EntreMed, Inc. (Nasdaq: ... therapeutics for the treatment of cancer, today reported results ... 31, 2011.   (Logo: http://photos.prnewswire.com/prnh/20010620/ENMDLOGO ) ... $1.9 million compared to $3.7 million for fiscal 2010. ...
... SQUARE, Pa., March 8, 2012  On the occasion of ... announce that interim data from an expanded clinical trial ... for safety and improved quality of life (QOL) previously ... The probiotic microbial strains in the product formulation are ...
... from North Carolina State University have developed the first ... in electronics, opening the door to an array of ... first time that researchers have been able to produce ... in a single oxide material, launching a new era ...
Cached Biology Technology:EntreMed Reports Fourth Quarter and Year-End 2011 Financial Results 2EntreMed Reports Fourth Quarter and Year-End 2011 Financial Results 3EntreMed Reports Fourth Quarter and Year-End 2011 Financial Results 4EntreMed Reports Fourth Quarter and Year-End 2011 Financial Results 5Interim Clinical Trial Results Confirm Safety of Renadyl™, a Probiotic Dietary Supplement for the Support of Healthy Kidney Function 2Interim Clinical Trial Results Confirm Safety of Renadyl™, a Probiotic Dietary Supplement for the Support of Healthy Kidney Function 3Functional oxide thin films create new field of oxide electronics 2
(Date:7/11/2014)... Researchers have pioneered a revolutionary new way to ... Virtual Finger, allows scientists to move through digital ... using the flat surface of their computer screens. ... orders of magnitude more efficient, saving time, money ... areas of experimental biology. The software and its ...
(Date:7/11/2014)... the normal circumstances, astrocytes participate in normal ... and exhibit therapeutic and repairing effects on ... have found that nerve cells differentiated from ... reduced viability, which produces influences on subsequent ... General Hospital, Hebei United University, China demonstrated ...
(Date:7/11/2014)... Janeiro, Brazil- In the brains of all vertebrates, ... allows an electric or chemical signal to be ... synapses, which are the most abundant type of ... formation is crucial for learning, memory, perception and ... synapses critical for brain function. For instance, ...
Breaking Biology News(10 mins):Virtual finger enables scientists to navigate and analyze complex 3D images 2Blame it on the astrocytes 2
... Dr. Eeva Karjalainen, of the Finnish Forest Research Institute, Metla, ... But not many of us know that there is also ... Forests and other natural, green settings can reduce ... happiness. Forest visits may also strengthen our immune system by ...
... This release is also available in ... also known as angiogenesis, is crucial for sustained tumor ... suppress the growth of these vessels have been available ... detection and quantification of blood vessel growth using nonsurgical ...
... distinguished government scientist Professor Robert (Bob) Watson who becomes ... Chief Scientific Advisor to the Department of Environment, Food ... Professor Watson is recognised for his contributions to scientific ... global warming. Professor Peter Heathcote, Head of the ...
Cached Biology News:Noninvasive MR imaging of blood vessel growth in tumors using nanosized contrast agents 2Noninvasive MR imaging of blood vessel growth in tumors using nanosized contrast agents 3Honorary Fellowship awarded to government Chief Scientific Advisor 2
Mouse monoclonal antibody raised against a partial recombinant L3MBTL2. NCBI Entrez Gene ID = L3MBTL2...
Mouse monoclonal antibody raised against a partial recombinant QARS. NCBI Entrez Gene ID = QARS...
96-well format (For processing samples on microplate-size MALDI target plates such as those from Bruker, Shimadzu, Thermo, and PerkinElmer) Packaging: 2 / pack...
... FUNNY SHAKERS are multi-functional mixing devices. Stepping ... is a solid, heavy-duty durable shaker to ... mixing and vortexing in nature. Regulated action ... with digital display to control time, continuous ...
Biology Products: